Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors
Huanyu Shi(Chinese Academy of Sciences), Bing Xiong(Chinese Academy of Sciences)
Cited by 1
Related Papers
Occupational exposure to SARS-CoV-2 in burns treatment during the COVID-19 epidemic: Specific diagnosis and treatment protocol
|Biomedicine & Pharmacotherapy|2020|52
Illudalic acid as a potential LAR inhibitor: Synthesis, SAR, and preliminary studies on the mechanism of action
|Bioorganic & Medicinal Chemistry|2008|28